(813) 971-8080

7210 Wareham Drive, Tampa, FL 33647

telemedicine

GLP-1 Drugs Market Update

Sept. 23, 2024 According to Becker’s Hospital Review… On Sept. 24, Novo Nordisk CEO Lars Fruergaard Jørgensen is slated to testify at a Senate committee hearing about the costs for Wegovy and Ozempic.  The hearing comes after months of disagreements between Denmark-based Novo Nordisk and the Senate Committee on Health, Education, Labor and Pensions. The

GLP-1 Drugs Market Update Read More »

Hims & Hers To Offer Certificates of Analysis for Compounded GLP-1s

August 1, 2024 In August, Certificates of Analysis on the compounded GLP-1 medications available through Hims & Hers will be accessible to customers, in an effort to introduce a higher level of transparency that helps our customers understand what is in the medications they receive, as well as how to understand the high quality standards

Hims & Hers To Offer Certificates of Analysis for Compounded GLP-1s Read More »

Scroll to Top